Wuhan Hiteck Biological Pharma Co Ltd - ESG Rating & Company Profile powered by AI
If you are employed by Wuhan Hiteck Biological Pharma Co Ltd and you wish to use your Sustainability aseessment, please get in touch. The webpage is a zero-cost Sustainability assessment for Wuhan Hiteck Biological Pharma Co Ltd. Browse to the end of the webpage for potential risks for Wuhan Hiteck Biological Pharma Co Ltd based on sector, location and marketcap.
Wuhan Hiteck Biological Pharma Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Wuhan Hiteck Biological Pharma Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Wuhan Hiteck Biological Pharma Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose current and historical energy intensity?
Does Wuhan Hiteck Biological Pharma Co Ltd report the average age of the workforce?
Does Wuhan Hiteck Biological Pharma Co Ltd reference operational or capital allocation in relation to climate change?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose its ethnicity pay gap?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose cybersecurity risks?
Does Wuhan Hiteck Biological Pharma Co Ltd offer flexible work?
Does Wuhan Hiteck Biological Pharma Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose the number of employees in R&D functions?
Does Wuhan Hiteck Biological Pharma Co Ltd conduct supply chain audits?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Wuhan Hiteck Biological Pharma Co Ltd conduct 360 degree staff reviews?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose the individual responsible for D&I?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose current and / or historical scope 2 emissions?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose water use targets?
Does Wuhan Hiteck Biological Pharma Co Ltd have careers partnerships with academic institutions?
Did Wuhan Hiteck Biological Pharma Co Ltd have a product recall in the last two years?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose incidents of discrimination?
Does Wuhan Hiteck Biological Pharma Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Wuhan Hiteck Biological Pharma Co Ltd issued a profit warning in the past 24 months?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose parental leave metrics?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose climate scenario or pathway analysis?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose the pay ratio of women to men?
Does Wuhan Hiteck Biological Pharma Co Ltd support suppliers with sustainability related research and development?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Wuhan Hiteck Biological Pharma Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Wuhan Hiteck Biological Pharma Co Ltd involved in embryonic stem cell research?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose GHG and Air Emissions intensity?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose its waste policy?
Does Wuhan Hiteck Biological Pharma Co Ltd report according to TCFD requirements?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose energy use targets?
Does Wuhan Hiteck Biological Pharma Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Wuhan Hiteck Biological Pharma Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Wuhan Hiteck Biological Pharma Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China. Its products include Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye, an acyclovir dispensable tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository drug; Xunkeyuan, a tinidazole suppository drug; and Shufu, a nimodipine sustained release tablets. The company also provides measles virus and rubella virus nucleic acid detection kit; mycoplasma isolation and identification kit and culture tube; bacterial vaginosis rapid detection kit; measles virus IgG antibody detection kit; and coronavirus N-protein detection kit. In addition, it offers Lopinavir and Ritonavir APIs; and intermediates. The company offers its products in the field of nervous system and oncology. Wuhan Hiteck Biological Pharma Co.,Ltd was founded in 1992 and is based in Wuhan, China.